(1) • Concerned Shareholders respond to Fancamp's press release dated April 1, 2021 regarding the termination of the Consulting Agreement with Peter H. Smith, and the groundless and inflammatory allegations made against him. • Concerned shareholders renew their demand that the entrenched board and management start acting in the best interests of the Company by calling the long overdue AGM as soon as possible and allowing shareholders to vote on the ScoZinc Transaction. Montreal, Quebec--(Newsfile Corp. - April 9, 2021) - Incumbent director of Fancamp, Dr. Peter H. Smith, who, together with joint actors, holds directly and indirectly an aggregate of 15,854,097 shares, representing approximately 9.55% of the Company's issued and outstanding common shares of Fancamp Exploration Ltd. ("Fancamp" or the "Company") (the "Concerned Shareholders"), regards the Company's press release dated April 1, 2021 as a preemptive smear campaign to tarnish the reputation of its co-founder, Dr. Peter H. Smith, and punish him for actually acting in the best interest of the Company. The fact that since Dr. Smith first requested and demanded that the board and management of Fancamp consider shareholders' interests and rights with respect to the highly dilutive plan of arrangement with ScoZinc Mining Inc. ("ScoZinc"), Fancamp board and management stopped paying him as per the terms of the consulting agreement ("Consulting Agreement") as a part of their continued bully tactics and threats that verge on intimidation if he was not to align himself with the Fancamp board and management. The actions taken on April 1, 2021 are not only deplorable, they show the lack of respect for an individual that has given more than half of his life to the betterment of the Company. Dr. Smith has been at Fancamp for over 35 years and has steered the Company in the right direction to the best of his abilities and it is now the current board and management's desire to put their own interests first through this ScoZinc transaction. There was no just cause for the termination of Dr. Smith's Consulting Agreement. The truth is this action has been taken as manner in which to avoid a discussion of the real issues of bad corporate governance, poor disclosure and lack of transparency.